CVE-2023-38954

Name: CVE-2023-38954
Creator: NVD / NIST
Published: 2023-08-03T02:15:09.65+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

CRITICALCVSS 9.8/10EPSS 0.52%

Last modified Jun 17, 2026

CVE-2023-38954 is a critical-severity vulnerability rated 9.8/10 on the CVSS scale. ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.. EPSS estimates a 0.52% chance of exploitation in the next 30 days.

Description

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

Metrics

CVSS 3.1

9.8/10

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS Probability

0.52%

40.1th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-89

Affected Software

Vendor	Product	Versions
Zkteco	Bioaccess Ivs	3.3.1

References

http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38954Third Party Advisory
http://zkteco.comNot Applicable
https://claroty.com/team82/disclosure-dashboard/cve-2023-38954Third Party Advisory

Timeline

Published: Aug 3, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2023-38954?

ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.

How severe is CVE-2023-38954?

CVE-2023-38954 has a CVSS score of 9.8/10 (CRITICAL severity). The EPSS model estimates a 0.52% probability of exploitation in the next 30 days.

How do I fix CVE-2023-38954?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2023-38954?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST